drugset
drugset / Trial / NCT06832540

Mass Balance Study of [14C] TJ0113 in Healthy Chinese Subjects

NCT06832540 ↗

Phase 1 Completed 6 enrolled Hangzhou PhecdaMed Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

Mass Balance Study of \[14C\] TJ0113 in Healthy Chinese Subjects

Timeline

Start
2025-02-19
Primary completion
2025-03-05
Completion
2025-03-05

Drugs

EvaluationDrugModalityDoseRoute
Subject TJ0113 Unknown 200 mg Oral

Indications

No indication recorded.